Healing / Recovery · Research guide

Thymosin Alpha-1: Healing / Recovery research guide

Educational research reference · For laboratory use only · Last reviewed 16 June 2026

Not medical advice. Thymosin Alpha-1 is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

🧬 In plain language

What Thymosin Alpha-1 is

Thymosin α1 is researched in immune-modulation and vaccine-adjuvant contexts; literature spans innate immunity and T-cell help in animal models.

One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.

Thymosin Alpha-1 (Zadaxin) 28-amino-acid thymic peptide activates TLR2/3/4/7/9 signaling for T-cell maturation. Approved in 30+ countries for immunomodulation.

Quick takeaways

  • Often categorised separately from TB-500–class fragments despite the shared “thymosin” name.
🔬 What scientists study

Research contexts

Peer-reviewed literature typically discusses Thymosin Alpha-1 in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.

Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.

Typical study contexts

  • Viral challenge and vaccine-response models in animals are common; endpoints include cytokine panels and cell counts.
  • Human use of thymosin-class compounds appears in formal clinical development in some regions, outside DIY or catalogue contexts.
  • Rodent and cell models of tendon, muscle, ligament, or gut injury, scientists track repair markers, cell migration, and inflammatory readouts.
  • Wound-healing and angiogenesis assays where the question is how tissue responds after controlled damage.
  • Occasional case-style write-ups in research settings; these are not substitutes for clinical evidence.
  • Peer-reviewed preclinical work sometimes describes experiments that track whether activates TLR2/3/4/7/9 signaling cascades triggering IRF3 and NF-κB downstream immune pathways
  • Peer-reviewed preclinical work sometimes describes experiments that track whether promotes CD4+ and CD8+ T-lymphocyte differentiation and functional maturation
  • Peer-reviewed preclinical work sometimes describes experiments that track whether augments NK cell cytotoxicity and dendritic cell antigen presentation efficiency
📚 Category

Why Healing / Recovery research matters

Compounds in this family are frequently studied in models of tissue injury, wound closure, and how cells reorganise after damage. Research looks at cell movement, blood-vessel support, and inflammatory balance -not at replacing medical care.

⚙️ From the literature

Mechanisms (technical review)

Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.

  • Activates TLR2/3/4/7/9 signaling cascades triggering IRF3 and NF-κB downstream immune pathways
  • Promotes CD4+ and CD8+ T-lymphocyte differentiation and functional maturation
  • Augments NK cell cytotoxicity and dendritic cell antigen presentation efficiency
  • Reduces all-cause sepsis mortality (RR 0.68) in pooled analysis of 12 randomized trials
  • Achieves 40.6% HBV DNA clearance at 6 months in controlled hepatitis B trials
  • Stimulates IL-2 and B-cell growth factor production with macrophage antigen presentation enhancement
🧪 Handling

Lab handling & preparation

Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.

Research dosing context: Literature typically discusses 1.6 mg (900 μg/m²) subcutaneously · Twice weekly · Subcutaneous Tmax ~2 hours. Serum t½ ~2 hours with return to baseline within 24 hours. Rapidly absorbed after SC injection. Amino acid sequence conserved across murine, bovine, and human species. Contraindicated in organ transplant recipients. Approved in 30+ countries as Zadaxin for hepatitis B/C and immune dysfunction.

Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.

❓ FAQ

Common Questions People Are Asking

What is Thymosin Alpha-1 and how does it work?

Thymosin Alpha-1 is a 28-amino-acid N-terminally acetylated thymic peptide derived from prothymosin alpha. It works by directly engaging multiple Toll-like receptors (TLR2/3/4/7/9) on innate immune cells, triggering IRF3, NF-κB, p38MAPK and MyD88 signalling, while also supporting maturation of CD4+/CD8+ T-cells, NK-cell cytotoxicity, and dendritic-cell antigen presentation. This dual innate-plus-adaptive action is why it is described as an immune rebalancer rather than a simple stimulant.

What does "immunomodulator" mean versus "immunostimulant"?

An immunostimulant broadly revs up immune activity; an immunosuppressant broadly shuts it down. An immunomodulator like Tα1 rebalances — it can amplify weak responses in immune-exhausted states like chronic viral infection, while helping calm overactivation in conditions like sepsis. The same molecule can do both because the immune system regulates itself differently in different states.

What does the clinical research actually show?

The evidence is genuinely mixed. Chronic hepatitis B studies reported higher HBV DNA clearance versus controls, and COVID-19 work suggested restoration of lymphocyte counts and reversal of T-cell exhaustion. But the rigorous multicentre phase-3 TESTS sepsis trial (2025) found no significant 28-day mortality benefit. So while the mechanism is well characterised, the clinical efficacy picture is not uniformly positive — and none of this is human-use guidance.

What dosing appears in the published literature?

Published clinical trials describe a 1.6 mg dose (approximately 900 μg/m² of body surface area) administered subcutaneously twice weekly, the schedule used across most of the sepsis, hepatitis B, and immune-support studies. Subcutaneous Tmax is roughly 2 hours and serum half-life around 2 hours, with return toward baseline within 24 hours. These are descriptive research parameters only; Tα1 is supplied for laboratory research.

How does Thymosin Alpha-1 differ from Thymulin or Thymopoietin?

They are all thymic peptides but completely different molecules with different mechanisms. Tα1 is a 28-residue peptide derived from prothymosin alpha that binds TLRs and supports T-cell maturation. Thymulin is a nonapeptide that requires zinc for activity, and thymopoietin is a 49-residue polypeptide. They are sometimes grouped together as "thymic factors" but act distinctly.

Is Thymosin Alpha-1 approved or legal?

Thymosin Alpha-1 is marketed as Zadaxin and approved as an immunomodulator in more than 30 countries, and it holds FDA orphan-drug designation for several indications — but it is not an FDA-approved drug for general therapeutic use in the United States. New-U supplies it strictly as a research-grade compound for in-vitro and preclinical laboratory research, not for human use; buyers are responsible for local compliance.

How should Thymosin Alpha-1 be stored and reconstituted?

Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water, refrigerate at 1–6 °C and protect from light. Tα1 is reasonably stable in solution within the normal peptide-handling window; avoid repeated freeze-thaw cycles. This is laboratory handling guidance only.

Is this page medical advice? Can I use Thymosin Alpha-1 for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find Thymosin Alpha-1 specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

🔗 Keep reading

Related peptide guides

Other compounds researchers often read about alongside Thymosin Alpha-1.

📑 References

Scientific sources & further reading

Primary literature and registries for Thymosin Alpha-1, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

Peptides in the news:

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

View product details

Also known as: Thymalfasin, Tα1, Ta1, Zadaxin, Thymosin α1, Thymosin Alpha 1, SciClone Thymalfasin, Immune Modulator Peptide